Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Public Health and Surveillance

Date Submitted: Oct 3, 2021
Date Accepted: Apr 27, 2022
Date Submitted to PubMed: Apr 29, 2022

The final, peer-reviewed published version of this preprint can be found here:

Reasons for COVID-19 Vaccine Hesitancy Among Chinese People Living With HIV/AIDS: Structural Equation Modeling Analysis

Chai R, Yang J, Zhang X, Huang X, Yu M, Fu G, Lan G, Qiao Y, Li S, Yao Y, Xu J

Reasons for COVID-19 Vaccine Hesitancy Among Chinese People Living With HIV/AIDS: Structural Equation Modeling Analysis

JMIR Public Health Surveill 2022;8(6):e33995

DOI: 10.2196/33995

PMID: 35486810

PMCID: 9255267

Reasons of COVID-19 Vaccine Hesitancy among Chinese People Living with HIV/AIDS: A Structural Equation Modeling Analysis

  • Ruiyu Chai; 
  • Jianzhou Yang; 
  • Xiangjun Zhang; 
  • Xiaojie Huang; 
  • Maohe Yu; 
  • Gengfeng Fu; 
  • Guanghua Lan; 
  • Ying Qiao; 
  • Shuyue Li; 
  • Yan Yao; 
  • Junjie Xu

ABSTRACT

Background:

Many countries and organizations recommended people living with HIV/AIDS (PLWHA) to receive the COVID-19 vaccine. However, vaccine hesitancy still exists and becomes a barrier for promoting COVID-19 vaccination among PLWHA.

Objective:

This study aims to investigate factors that contributed to COVID-19 vaccine hesitancy among PLWHA.

Methods:

The study used a multicenter cross-sectional design and an online survey mode. We recruited PLWHA aged 18-65 years old from five metropolitan cities in China between January and February 2021. Participants completed an online survey through the Golden Data, a widely used encrypted web-based survey platform. Multiple linear regression models were used to assess the background characteristics in relation to COVID-19 vaccine hesitancy, and structural equation modeling was performed to assess the relationships among perceived benefits, perceived risks, self-efficacy, subjective norms, and COVID-19 vaccine hesitancy.

Results:

Among 1735 participants, 41.61% (722/1735) reported COVID-19 vaccine hesitancy. An older age, no other vaccinations in the past 3 years, and having chronic disease history were positively associated with COVID-19 vaccine hesitancy. Structural equation modeling revealed a direct relationship of perceived benefits, perceived risks, and subjective norms with self-efficacy and vaccine hesitancy and an indirect relationship of perceived benefits, perceived risks, and subjective norms with vaccine hesitancy. Moreover, the self-efficacy toward COVID-19 vaccination was low. PLWHA had concerns of HIV disclosure during COVID-19 vaccination. Family members support could have an impact on the COVID-19 vaccination decision-making.

Conclusions:

COVID-19 vaccine hesitancy was high among PLWHA in China. To reduce COVID-19 vaccine hesitancy, programs and strategies should be adopted to eliminate the concerns for COVID-19 vaccination, disseminate accurate information on the safety and efficacy of the COVID-19 vaccine, encourage family members support for COVID-19 vaccination, and improve PLWHA’s trust on medical professionals.


 Citation

Please cite as:

Chai R, Yang J, Zhang X, Huang X, Yu M, Fu G, Lan G, Qiao Y, Li S, Yao Y, Xu J

Reasons for COVID-19 Vaccine Hesitancy Among Chinese People Living With HIV/AIDS: Structural Equation Modeling Analysis

JMIR Public Health Surveill 2022;8(6):e33995

DOI: 10.2196/33995

PMID: 35486810

PMCID: 9255267

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.